PEARL RIVER, N.Y.–(Enterprise WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) these days delivered a thorough, lengthy-time period business enterprise system to travel shareholder worth and also supplied prolonged-expression monetary steering. Acorda has made a extensive-term small business strategy to enhance the worth of the Company, focused on escalating INBRIJA® (levodopa inhalation powder), […]